Cargando…

Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter?

BACKGROUND: Metabolic-associated fatty liver disease (MAFLD) is the commonest cause of abnormal liver function tests (LFTs). Current upper normal of limit (UNL) of LFTs was derived from a “healthy” population, where undiagnosed MAFLD and viral hepatitis might be suspected. AIM: To evaluated potentia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Forlano, Roberta, Mullish, Benjamin H, Dhar, Ameet, Goldin, Robert D, Thursz, Mark, Manousou, Pinelopi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727198/ https://www.ncbi.nlm.nih.gov/pubmed/35070011 http://dx.doi.org/10.4254/wjh.v13.i12.2104

Ejemplares similares

The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease
por: Forlano, Roberta, et al.
Publicado: (2022)

Metabolic Profile Reflects Stages of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Jambulingam, Nila, et al.
Publicado: (2023)

Gut Microbiota—A Future Therapeutic Target for People with Non-Alcoholic Fatty Liver Disease: A Systematic Review
por: Forlano, Roberta, et al.
Publicado: (2022)

Current and future pharmacological therapies for managing cirrhosis and its complications
por: Kockerling, David, et al.
Publicado: (2019)

Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical Perspective
por: Huang, Jian, et al.
Publicado: (2023)

High-Throughput, Machine Learning–Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease
por: Forlano, Roberta, et al.
Publicado: (2020)

Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non‐alcoholic fatty liver disease; the importance of an elevated mean platelet volume
por: Abeles, Robin D., et al.
Publicado: (2019)

Non-alcoholic fatty liver disease in women – Current knowledge and emerging concepts
por: Eng, Pei Chia, et al.
Publicado: (2023)

Screening for NAFLD—Current Knowledge and Challenges
por: Forlano, Roberta, et al.
Publicado: (2023)

In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19
por: Forlano, Roberta, et al.
Publicado: (2020)

Thrombin and factor Xa link the coagulation system with liver fibrosis
por: Dhar, Ameet, et al.
Publicado: (2018)

Cardiac risk factors limiting survival to liver transplantation in patients with nonalcoholic fatty liver disease
por: Delicce, Michael, et al.
Publicado: (2022)

Influence of non-alcoholic fatty liver disease on non-variceal upper gastrointestinal bleeding: A nationwide analysis
por: Soni, Aakriti, et al.
Publicado: (2023)

THU642 Progression To Cirrhosis And All-cause Mortality Are Increased In Postmenopausal Women With NAFLD
por: Izzi-Engbeaya, Chioma, et al.
Publicado: (2023)

Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales
por: Michalak, Agata, et al.
Publicado: (2020)

The effects of dietary supplementation with inulin and inulin‐propionate ester on hepatic steatosis in adults with non‐alcoholic fatty liver disease
por: Chambers, Edward S., et al.
Publicado: (2018)

Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder
por: Kim, Jin Un, et al.
Publicado: (2020)

Effects of proprotein convertase subtilisin/kexin type-9 inhibitors on fatty liver
por: Shafiq, Muhammad, et al.
Publicado: (2020)

Revision of serum ALT upper limits of normal facilitates assessment of mild liver injury in obese children with non‐alcoholic fatty liver disease
por: Lu, Yutian, et al.
Publicado: (2020)

Proteomic analysis of extracellular matrix from the hepatic stellate cell line LX-2 identifies CYR61 and Wnt-5a as novel constituents of fibrotic liver
por: Rashid, S. Tamir, et al.
Publicado: (2012)

Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry
por: Fujita, Nobuhiro, et al.
Publicado: (2016)

Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients
por: Yuan, Xian-Xian, et al.
Publicado: (2019)

Sex-influenced association of non-alcoholic fatty liver disease with colorectal adenomatous and hyperplastic polyps
por: Chen, Qin-Fen, et al.
Publicado: (2017)

Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study
por: Bertol, Franciele Sabadin, et al.
Publicado: (2020)

Association of maternal obesity and gestational diabetes mellitus with overweight/obesity and fatty liver risk in offspring
por: Zeng, Jing, et al.
Publicado: (2022)

Clinic-pathological features of metabolic associated fatty liver disease with hepatitis B virus infection
por: Wang, Ming-Fang, et al.
Publicado: (2021)

Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina
por: Piñero, Federico, et al.
Publicado: (2018)

Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
por: Fujimori, Naoyuki, et al.
Publicado: (2018)

Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease
por: Zeng, Jing, et al.
Publicado: (2020)

Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population
por: Kichloo, Asim, et al.
Publicado: (2021)

Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
por: Wu, Yin-Lian, et al.
Publicado: (2021)

Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis
por: Kimura, Takefumi, et al.
Publicado: (2018)

Improvement in liver stiffness measurement for diagnosis of liver fibrosis in patients with concurrent chronic hepatitis B and nonalcoholic fatty liver disease
por: Xu, Nan, et al.
Publicado: (2020)

Severe cholestatic jaundice after a single administration of ajmaline; a case report and review of the literature
por: Mullish, Benjamin H, et al.
Publicado: (2014)

Predicting liver and lung metastasis in esophageal cancer: does the site of primary tumor really matter?
por: Lam, Ka-On, et al.
Publicado: (2020)

Reduced upper limb lean mass on dual energy X-ray absorptiometry predicts adverse outcomes in male liver transplant recipients
por: Hey, Penelope, et al.
Publicado: (2022)

Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES database
por: Atsawarungruangkit, Amporn, et al.
Publicado: (2021)

Peptic ulcer disease in non-alcoholic fatty liver disease hospitalizations: A new challenge on the horizon in the United States
por: Dahiya, Dushyant Singh, et al.
Publicado: (2023)

Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis
por: Hoffmann, Peter, et al.
Publicado: (2020)

Combination of type IV collagen 7S, albumin concentrations, and platelet count predicts prognosis of non-alcoholic fatty liver disease
por: Kawanaka, Miwa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_84r2cdsm11n2s70l84ev1pr9d0